Deals

nuaxia

10 hours ago3 min read

Sanofi and Lilly Back AdvanCell’s $315M Radiopharmaceutical Expansion as ADVC001 Moves Towards Late-Stage Development

nuaxia

1 day ago3 min read

Lilly to Acquire AtaiBeckley in Up to $3.8bn Deal to Expand into Psychedelic Depression Therapies

nuaxia

1 day ago3 min read

XRHealth Acquires Swing Therapeutics to Expand Digital Chronic Pain Care Platform

nuaxia

3 days ago3 min read

AstraZeneca Acquires Global Rights to Dizal’s Zegfrovy in $1.5bn Lung Cancer Deal

nuaxia

3 days ago4 min read

Draig Therapeutics Raises $65M to Advance AMPA Modulator DT-101 for Depression Treatment

nuaxia

3 days ago3 min read

Insilico Medicine and China Medical System Expand AI Drug Discovery Partnership with $177m CNS Deal

nuaxia

4 days ago3 min read

Bayer Secures €3bn Apollo Investment in Contraceptives Business as Pharma Strategy Evolves

nuaxia

Jul 103 min read

AstraZeneca Licences Sino Biopharmaceutical’s TQC3721 Respiratory Drug in Potential $1.9bn Deal

nuaxia

Jul 102 min read

Leo Cancer Care Raises $65m to Expand Upright Radiotherapy Platform

nuaxia

Jul 93 min read

Vertex Acquires Crinetics for $10B to Expand into Endocrinology

nuaxia

Jul 92 min read

VB Spine Expands Surgical Navigation Portfolio with Augmedics CT-Fluoro Technology Deal

nuaxia

Jul 93 min read

Ottobock Acquires Fesia Technology to Expand Neurorehabilitation Portfolio

nuaxia

Jul 93 min read

Novo Nordisk Explores Long-Acting Semaglutide Implant Through Vivani Partnership

nuaxia

Jul 93 min read

Kalohexis Files Confidentially for IPO to Advance Obesity and Cachexia Pipeline

nuaxia

Jul 93 min read

AstraZeneca Expands China Partnerships with Up to $2.1bn Respiratory Drug Deal

nuaxia

Jul 73 min read

PureTech-Backed Celea Raises $180m to Challenge Established IPF Treatments

nuaxia

Jul 72 min read

Roche Strengthens Breast Cancer Pipeline with $490m+ Astex Partnership

nuaxia

Jul 73 min read

Novartis Acquires Myricx Bio in Up to $1.5bn Deal to Strengthen ADC Pipeline

nuaxia

Jul 72 min read

Scribe Therapeutics Moves Toward Nasdaq Debut as CRISPR Pipeline Advances Into Clinic

nuaxia

Jul 52 min read

Sanofi and Lilly Back AdvanCell’s $315M Radiopharmaceutical Expansion as ADVC001 Moves Towards Late-Stage Development

Lilly to Acquire AtaiBeckley in Up to $3.8bn Deal to Expand into Psychedelic Depression Therapies

XRHealth Acquires Swing Therapeutics to Expand Digital Chronic Pain Care Platform

AstraZeneca Acquires Global Rights to Dizal’s Zegfrovy in $1.5bn Lung Cancer Deal

Draig Therapeutics Raises $65M to Advance AMPA Modulator DT-101 for Depression Treatment

Insilico Medicine and China Medical System Expand AI Drug Discovery Partnership with $177m CNS Deal

Bayer Secures €3bn Apollo Investment in Contraceptives Business as Pharma Strategy Evolves

AstraZeneca Licences Sino Biopharmaceutical’s TQC3721 Respiratory Drug in Potential $1.9bn Deal

Leo Cancer Care Raises $65m to Expand Upright Radiotherapy Platform

Vertex Acquires Crinetics for $10B to Expand into Endocrinology

VB Spine Expands Surgical Navigation Portfolio with Augmedics CT-Fluoro Technology Deal

Ottobock Acquires Fesia Technology to Expand Neurorehabilitation Portfolio

Novo Nordisk Explores Long-Acting Semaglutide Implant Through Vivani Partnership

Kalohexis Files Confidentially for IPO to Advance Obesity and Cachexia Pipeline

AstraZeneca Expands China Partnerships with Up to $2.1bn Respiratory Drug Deal

PureTech-Backed Celea Raises $180m to Challenge Established IPF Treatments

Roche Strengthens Breast Cancer Pipeline with $490m+ Astex Partnership

Novartis Acquires Myricx Bio in Up to $1.5bn Deal to Strengthen ADC Pipeline

Scribe Therapeutics Moves Toward Nasdaq Debut as CRISPR Pipeline Advances Into Clinic

Celea Therapeutics Secures $180m to Advance Phase III IPF Programme